紅星美凱龍(01528.HK)擬申請發行北京金融資產交易所債權融資計劃
格隆匯 10 月 30日丨紅星美凱龍(01528.HK)公告,為了進一步拓寬公司融資渠道,改善紅星美凱龍家居集團股份有限公司(以下簡稱“公司”)債務結構,補充公司經營所需流動資金,公司擬申請發行北京金融資產交易所(以下簡稱“北金所”)債權融資計劃(非公開定向債務融資)(以下簡稱“債權融資計劃”),具體情況如下:
1.註冊額度:不超過5億元。
2.發行期限:不超過3年。
3.發行利率:按面值發行,發行利率根據發行時債券市場的市場狀況,通過掛牌定價、集中配售的結果確定發行利率。
4.募集資金用途:償還公司及下屬子公司的債務、補充營運資金及適用的法律法規允許的其他用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.